How large is the hemostasis diagnostic devices and equipment market, and what is its growth trajectory?
The hemostasis diagnostic devices and equipment market size has grown rapidly in recent years. It will grow from $5.29 billion in 2024 to $6.18 billion in 2025 at a compound annual growth rate (CAGR) of 16.8%. The growth in the historic period can be attributed to clinical diagnostics, surgical procedures, anticoagulant therapy monitoring, hemophilia and bleeding disorders.
The hemostasis diagnostic devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $10.36 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to aging population, cardiovascular and chronic diseases, personalized medicine, rising surgical procedures. Major trends in the forecast period include point-of-care testing, automation and robotics, biomarker discovery, telemedicine and remote monitoring.
Get Your Free Sample of The Global Hemostasis Diagnostic Devices And Equipment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2598&type=smp
What are the key forces behind the hemostasis diagnostic devices and equipment market’s growth in recent years?
The increased likelihood of older people being diagnosed with a disease is driving the number of surgeries for cardiovascular diseases (CVD) using hemostasis devices. Due to the higher incidence of diseases with advancing age, there is an increase in the number of surgeries for elderly patients nowadays. These hemostasis devices are very efficient in speeding up the natural process of clotting in the blood and can monitor anticoagulation and transfusion therapy guidance in any surgery. According to the American Heart Association report, Americans older than 80 have a high risk of developing cardiovascular disease (CVD) around 83% of men and 87.1% of females will be suffering from any form of CVD, therefore, to improve the comfort of the patient and the success rate of surgeries as a result hemostasis device has been implemented widely.
What are the major segments of the hemostasis diagnostic devices and equipment market?
The hemostasis diagnostic devices and equipment market covered in this report is segmented –
1) By Product: Analyzers, Coagulation Instrument, Other Hemostasis Instruments, Reagents and Kits
2) By Device Technology: Automated, Semi-Automated, Manual
3) By End User: Hospitals, Clinics, Independent Diagnostic, Laboratories, Other End Users
Subsegments:
1) By Analyzers: Hematology Analyzers, Platelet Function Analyzers, Thromboelastography (TEG) Analyzers
2) By Coagulation Instruments: Prothrombin Time (PT) Instruments, Activated Partial Thromboplastin Time (aPTT) Instruments, Fibrinogen Testing Instruments, Thrombin Time (TT) Instruments
3) By Other Hemostasis Instruments: Blood Clotting Time (BCT) Instruments, Bleeding Time (BT) Test Devices, Hemostatic Forceps and Clips
4) By Reagents and Kits: Coagulation Reagents, Blood Collection Kits, Point-of-care Testing Kits, Thrombosis Kits
Order your report now for swift delivery
Which companies dominate the hemostasis diagnostic devices and equipment market?
Major companies operating in the hemostasis diagnostic devices and equipment market include C. R. Bard Inc., Baxter International Inc., Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Chrono-Log Corporation, CSL Behring LLC, F. Hoffmann-La Roche Ltd., Grifols S.A., HemCon Medical Technologies Inc., Integra Life Sciences Corporation, Medtronic plc, Siemens AG, Thermo Fisher Scientific Inc., Trinity Biotech plc., Ethicon Inc., Boston Scientific Corporation, Olympus Corporation, Cook Group Inc., Halyard Health, Medline Industries Inc., ConMed Corporation, Moog Inc., Argon Medical Devices Inc., B. Braun Interventional Systems Inc., Bio-Rad Laboratories Inc., CareFusion Corporation, Danaher Corporation, DemeTECH Corporation, Diagnostica Stago SAS, Dolphin Sutures, EndoEvolution LLC, Haemonetics Corporation, Internacional Farmacéutica S.A. de C.V., Merit Medical Systems Inc., Quidelortho Corp, STAGO, Stryker Corporation
How will industry trends affect the trajectory of the hemostasis diagnostic devices and equipment market?
The emergence of new and improved technology in the hemostasis diagnostic device and equipment market. To improve the quality and success rate of operations, new and improved technology such as collagen vascular hemostasis devices have been implemented. Collagen is the main structural protein found in skin and other connective tissues. It is widely used in purified form for cosmetic surgical treatments and has now emerged in the hemostasis diagnostic devices market. A patient can face immobility right after a femoral surgery leading to increased discomfort, as a result, collagen-based closure devices have been implemented. According to a study conducted by the American Journal of Neuroradiology which surveyed 698 Angio-Seal closures, using the Angio seal reduced the average time before mobilization by close to 15 minutes with no major complications. Angio seal is a type of collagen hemostasis device that reduces the average time of hemostasis and betters the mobilization of the patient.
What are the key regional dynamics of the hemostasis diagnostic devices and equipment market, and which region leads in market share?
North America was the largest region in the global hemostasis diagnostic devices and equipment market in 2023. Asia-Pacific was the second-largest region in the hemostasis diagnostic devices and equipment market. The regions covered in the hemostasis diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Hemostasis Diagnostic Devices And Equipment Market Report 2025 Offer?
The hemostasis diagnostic devices and equipment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Hemostasis diagnostic devices and equipment are specialized tools used to assess the blood clotting process and diagnose bleeding disorders. These devices help healthcare professionals monitor and evaluate various aspects of hemostasis, such as clot formation and dissolution.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2598
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
